PeproStat as a Topical Agent Used to Stop Bleeding in Patients Undergoing Surgery

Summary

The purpose of this study is to test the effectiveness and safety of a new peptide-based coagulant, PeproStat. The study drug will be applied to patients undergoing liver/soft tissue surgery, vascular surgery or spine surgery. The speed of action of the new coagulant, that is applied with a gelatin sponge, will be compared to the same sponge but with saline (a commonly used standard of care).

Timeline

Start

2017-03-31

Primary completion

2017-08-23

Completion

2017-10-11

Drugs

Indications